Trade secrets: an alternative for life sciences IP?

Over the past decade, three high-profile US Supreme Court decisions—known by their shorthand names as Alice, Mayo, and Myriad—have generated significant uncertainty over what is and isn’t patentable.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

MedTech

Insulet asks Fed Circ to rehear $59.4m trade secret reversal

3 August 2026 The medical device maker says that a split appellate decision raises broader questions about trade secret law, jurisdiction and when the clock starts ticking on misappropriation claims.

Careers

Arnold & Porter adds firepower to ITC practice with new partner hire

3 August 2026 Appointment strengthens the firm’s expertise in US International Trade Commission proceedings and cross-border intellectual property disputes.

Pharma

USPTO director steps into Sun Pharma’s PTAB-ITC clash

31 July 2026 A director review has overturned a PTAB ruling, questioning why it diverged from an ITC decision based on the same patent claims, prior art and evidence.

More features

Insulet asks Fed Circ to rehear $59.4m trade secret reversal

Fish & Richardson adds AI and medical device specialist

FisherBroyles and Hong Kong affiliate draft in senior partners

‘Engagement and collaboration’: New IP Federation president builds on strong foundations

AbbVie, Allergan takes on Swiss aesthetics rival over syringe design

Pharmascience v Janssen: Canada court updates methods of medical treatment protection

Masimo keeps $634m smartwatch award and moves to appeal

Pillsbury nabs ‘veteran’ IP litigator and trial lawyer from Goodwin

Trade secrets: an alternative for life sciences IP?

More on this story

Editor's picks

Editor's picks

More features